Research Products and Multi-Vial Collections
Research Summary
Metabolic Max combines two research compounds frequently studied in laboratory environments for their involvement in metabolic signaling pathways and cellular energy production systems.
Research investigations commonly examine:
- Multi-receptor incretin signaling pathways
- Cellular energy metabolism systems
- Mitochondrial function and redox balance
- NAD+-dependent enzymatic activity
- Integrated metabolic signaling networks
By combining receptor-mediated signaling compounds with intracellular energy coenzymes, laboratory models can explore complex biochemical systems involving both endocrine signaling pathways and cellular energy regulation mechanisms.
Available Vial Options
Stack Composition
The Metabolic Max research stack includes the following compounds:
- Reta-GLP3-Rta — multi-receptor incretin agonist peptide studied for interaction with GLP-1, GIP, and glucagon receptor signaling pathways
- NAD+ (Nicotinamide Adenine Dinucleotide) — cellular coenzyme studied for its role in mitochondrial function and intracellular energy metabolism
Together, these compounds provide a dual-system research model involving both receptor-mediated metabolic signaling and cellular energy production systems.
Technical Specifications
| Product Name | Metabolic Max |
| Product Category | Multi-compound peptide research stack |
| Stack Components | GLP3-Rta NAD+ |
| GLP3-Rta Vial Size | 60mg |
| NAD+ Vial Size | 1000mg |
| Purity | ≥99% (HPLC verified) |
| Testing Location | Tested and verified in the USA |
| Testing | Third-party verified |
| Intended Use | Laboratory research only |
Research Compound Profile
| Attribute | Description |
|---|---|
| Stack Type | Multi-compound peptide research stack |
| Component Peptides | GLP3-Rta |
| Additional Compounds | NAD+ |
| Research Category | Metabolic signaling and energy systems |
| Compound Form | Lyophilized powders |
| Purity Verification | ≥99% via HPLC |
Mechanism of Action
In laboratory models, the compounds within the Metabolic Max stack are examined for their interaction with multi-receptor incretin signaling systems and intracellular energy metabolism pathways.
Reta-GLP3-Rta is studied for its interaction with incretin receptor signaling pathways, including:
- GLP-1 receptor signaling
- GIP receptor signaling
- Glucagon receptor signaling
These receptor systems are frequently investigated for their role in metabolic regulation and endocrine signaling networks.
NAD+ is studied for its involvement in cellular energy production systems, including:
- Mitochondrial respiration pathways
- Redox reactions and electron transport systems
- NAD+-dependent enzymatic processes
Research investigations explore how these compounds may influence:
- Integrated metabolic signaling pathways
- Cellular energy production systems
- Mitochondrial function and biochemical energy balance
- Multi-system metabolic interaction models
The combination of receptor-mediated incretin signaling and intracellular energy coenzymes allows researchers to examine complex metabolic systems within controlled laboratory environments.
Areas of Scientific Investigation
Preclinical and mechanistic studies examining metabolic and energy systems frequently investigate:
- Multi-receptor incretin signaling pathways
- Cellular energy metabolism systems
- Mitochondrial function and redox biology
- NAD+-dependent biochemical processes
- Integrated metabolic signaling models
All references reflect controlled laboratory research environments only and do not imply therapeutic application.
Storage & Handling
- Store lyophilized compounds at 2–8°C
- Protect from light and moisture
- Maintain sterile laboratory handling conditions
- Reconstituted materials should be managed according to research protocol standards
Quality & Verification
PeptideBlend research compounds are:
- Tested and verified in the United States
- Produced under controlled laboratory conditions
- Third-party tested for identity and purity
- Verified at ≥99% purity via HPLC analysis
Certificates of Analysis (COA) available upon request.
Frequently Asked Questions
What is the Metabolic Max stack?
Metabolic Max is a multi-compound peptide research stack combining Reta-GLP3-Rta and NAD+, studied in laboratory environments for their interaction with metabolic signaling pathways and cellular energy systems.
What compounds are included in the Metabolic Max stack?
The stack includes:
- Reta-GLP3-Rta
- NAD+
These compounds are studied in laboratory research models examining metabolic signaling and energy production systems.
What research areas investigate compounds such as Reta-GLP3-Rta and NAD+?
Laboratory investigations frequently examine:
- Incretin receptor signaling systems
- Cellular energy metabolism pathways
- Mitochondrial function and redox systems
Is the Metabolic Max stack intended for human use?
No. This product is supplied strictly for laboratory research and analytical purposes.
Scientific Literature Context
Scientific literature examining incretin receptor agonists and cellular energy coenzymes frequently investigates metabolic signaling pathways and intracellular energy systems.
Research involving compounds such as Reta-GLP3-Rta and NAD+ contributes to the understanding of complex metabolic regulation systems studied within controlled laboratory environments.
Research Use Disclaimer
This product is intended strictly for laboratory research and analytical purposes only.
Not for human consumption.
Not for diagnostic, therapeutic, or veterinary use.
PeptideBlend does not market or sell products for medical or pharmaceutical application.